Filter results
You can narrow down the results using the filters
Topic
- Advertising (214)
- COVID-19 (117)
- Medicines safety (93)
- COVID-19 vaccines (70)
- Prescription medicines (69)
- Regulatory compliance (69)
- Legislation (61)
- Medicines (56)
- Medical devices safety (35)
- Listed medicines (33)
- Medical devices (33)
- Non-prescription medicines (28)
- Therapeutic goods regulation (24)
- Manufacturing (22)
- Assessed listed medicines (21)
- Complementary medicines (21)
- Scheduling (national classification system) (21)
- Unapproved therapeutic goods (17)
- Labelling and packaging (15)
- Safety (13)
- Medicinal cannabis hub (10)
- Nicotine vaping products hub (10)
- Shortages (10)
- Over the counter medicine (9)
- Import and export (8)
- Sunscreens (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Alert/Advisory (4)
- Compliance and enforcement hub (3)
- Advisory bodies and committees (2)
- Biologicals (2)
- Fees and payments (2)
- Weight loss products (2)
- Biological medicines (1)
- Blood and blood components (1)
- Blood safety (1)
- Clinical trials (1)
- Cosmetics (1)
- Other therapeutic goods (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) Hub (1)
Search
901 result(s) found, displaying 51 to 75
- NewsLimited Ozempic supplies to commence distribution in AustraliaSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.
- NoticesTherapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Famtozinameran) Labelling Exemption 2023This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 09-02-23Information about the TGA's safety monitoring of COVID-19 vaccines.
- Safety updatesAvoid prescribing pregabalin in pregnancy if possibleMedicines Safety Update - Information for health professionals
- NoticesDirection about advertisements: Melbourne-based individualThe TGA has issued a direction notice to a Melbourne-based individual to cease advertising of all nicotine vaping products.
- Media releasesChange to classification of psilocybin and MDMA to enable prescribing by authorised psychiatristsFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
- Media releasesTGA makes interim decision to reduce maximum paracetamol pack sizesThe TGA has today published an interim decision to reduce the maximum pack sizes for various paracetamol products.
- Media releasesCaveman Nutrition Pty Ltd, The Cave Nutrition Store Pty Ltd and their director fined $208,000 for alleged unlawful advertising of sports supplements containing dangerous substancesThe TGA has issued infringement notices to Caveman Nutrition Pty Ltd, The Cave Nutrition Store Pty Ltd and to the director of these companies for the alleged unlawful advertising of sports supplements and therapeutic goods not included in the ARTG.
- Media releasesJSHealth Vitamins Pty Ltd fined $13,320 for alleged unlawful supply of a complementary medicineThe TGA has issued an infringement notice totalling $13,320 to Sydney company JSHealth Vitamins Pty Ltd for supplying a complementary medicine that allegedly did not conform with legal requirements.
- NewsChanges applying to evaluation of new substances for listed medicinesNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
- Media releasesTGA confirms the performance of Australian approved Rapid Antigen Tests with COVID-19 VariantsThe TGA has confirmed the performance of COVID-19 rapid antigen tests available on the Australian market with COVID-19 variants.
- NoticesTherapeutic Goods (Permissible Ingredients - Application for Variation) Approval 2023This instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.
- Media releasesMode Medical Pty Ltd and executive officer fined almost $160,000 for alleged unlawful advertising of intravenous infusion productsThe TGA has issued infringement notices to Mode Medical Pty Ltd for the alleged unlawful advertising to Australian consumers on a company website and social media.
- Safety updatesProduct Information safety updates - January 2023Medicines Safety Update - Information for health professionals
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 27-01-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional approval to Pfizer’s COVID-19 bivalent (COMIRNATY Original/Omicron BA.4-5 COVID-19 vaccine) booster dose vaccineThis is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.
- Media releasesTGA commences evaluation of Moderna COVID-19 vaccine (SPIKEVAX) for potential transition to full registrationThe TGA has commenced evaluation of an application from Moderna Australia Pty Ltd to transition its COVID-19 vaccine, SPIKEVAX, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report – 12-01-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsAntibiotics shortage in AustraliaCurrent antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 22-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsAccess Generic Medicines work-sharing initiative updateThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
- Safety updatesProduct Information safety updates - December 2022Medicines Safety Update - Information for health professionals
- NewsTGA operations over the holiday period 2022-23The TGA will have limited operations from Friday 23 December 2022 until Tuesday 3 January 2023
- Media releasesTravellers with injectable medicines containing ingredients derived from animal or human origin no longer require TGA approval to enter AustraliaTravellers will be able to bring up to 3-months supply of their medicine.